Birth Control Spotlight
  • Saved

4yr
Follicular fluid and blood levels of persistent organic pollutants and reproductive outcomes among women undergoing assisted reproductive technologies - PubMed

Follicular fluid and blood levels of persistent organic pollutants and reproductive outcomes among women undergoing assisted reproductive technologies - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34973191/

Persistent organic pollutants (POPs) are industrial chemicals resistant to degradation and have been shown to have adverse effects on reproductive health in wildlife and humans. Although regulations have reduced their...


Conclusion/Relevance: We strongly encourage further studies to elucidate the underlying mechanisms of reproductive effects of POPs in humans.

  • Saved

4yr
Primary bilateral inguinal endometriosis: A case report

Primary bilateral inguinal endometriosis: A case report

Source : https://www.sciencedirect.com/science/article/pii/S2210261222001997?via=ihub

Endometriosis is a benign, recurrent, painful disease of reproductive-age women. * The inguinal area is a rare extra-pelvic location of endometriosis. * Surgical excision is often the treatment of choice...


Conclusion: We would like to highlight the atypical presentation, pathogenesis, and management of endometriosis in this rare site.

  • Saved

4yr
Toxic: The Challenge of Involuntary Contraception in Incompetent Psychiatric Patients Treated with Teratogenic Medication - PubMed

Toxic: The Challenge of Involuntary Contraception in Incompetent Psychiatric Patients Treated with Teratogenic Medication - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35302516/

Limitations on reproductive decision making, including forced sterilization and involuntary birth control, raise significant ethical challenges. In the United States, these issues are further complicated by a disturbing history of...


Conclusion/Relevance: This article examines the ethical issues involved in the use of involuntary LARC for patients on teratogenic psychiatric medications (TPMs) and argues that such an approach can only be justified as a last resort after a careful consideration of the alternatives and an assessment of potential risks and benefits.

  • 4yr
    Limitations on reproductive decision making, including forced sterilization and involuntary birth control, raise significant ethical challenges
  • Saved

4yr
Effects of oral contraceptives plus orlistat in patients with polycystic ovary syndrome and overweight/obesity: A meta-analysis - PubMed

Effects of oral contraceptives plus orlistat in patients with polycystic ovary syndrome and overweight/obesity: A meta-analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35302695/

This combination treatment of OCP and orlistat was more effective than OCP alone in reducing the weight, hormonal, lipid, and insulin metabolism profiles, as well as improving the ovulation rate,...


Conclusion: This combination treatment of OCP and orlistat was more effective than OCP alone in reducing the weight, hormonal, lipid, and insulin metabolism profiles, as well as improving the ovulation rate, pregnancy rate, and overall effective rate, as compared with OCP alone.

  • 4yr
    combination treatment of OCP and orlistat was more effective than OCP alone in reducing the weight, hormonal, lipid, and insulin metabolism profiles
  • Saved

made a Post

4yr
Considerations for initiating long-acting, reversible contraceptives

Unintended pregnancies pose a significant public health risk and account for 45% of all pregnancies in the US, with 41% caused by inconsistent use of contraceptives. This highlights the current need for modern contraception with enhanced compliance. The Practice Bulletin from the American College of Obstetricians and Gynecologists indicates long-acting reversible contraceptives (LARC) are the most effective reversible contraceptive methods because women can have long-term effective contraception with a single intervention. Yet, fewer than 15% of women choose a traditional LARC and 20-30% of women have their IUD or implant removed within one year.

1. For patients that are hesitant or decline traditional LARCs, what additional/alternative birth control options could be considered?
2. What are the reasons why some patients are more likely to switch to a long-lasting alternative birth control?

Footer:
Guttmacher Institute. Contraceptive Use in the United States Fact Sheet, July 2018.

ACOG Practice Bulletin: Long-Acting Reversible Contraception: Implants and Intrauterine Devices, Number 186 (https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/11/long-acting-reversible-contraception-implants-and-intrauterine-devices)

CDC US Selected Practice Recommendations (US SPR) for Contraceptive Use, 2016 (https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/summary.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Freproductivehealth%2Fcontraception%2Fusspr.htm)

Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65(RR-3):1–103. (Level III) Kavanaugh ML, et al. F&S Reports, 2020, 1(2):83-93, https://www.fertstertreports.org/article/S2666-3341(20)30038-6/fulltext.

Diedrich JT, Zhao Q, Madden T, et al. Three-year continuation of reversible contraception. Am J Obstet Gynecol, 2015;213:662.e1-8.

  • 4yr
    Most of my patients do actually like the intrauterine LARCs but some do not; most common reason being the thought of a 'surgical procedure' and 'associated pain' during placement, also Show More
  • 4yr
    I prescribe quite a bit of isotretinoin for acne and in my opinion the LARC's are the safest for young women to prevent pregnancy. Especially for younger women. I Show More

Show More Comments